Aim: The aim of the current study was to isolate and identify naturally occurring probiotic Lactobacillus species in different animals with the different environmental background including fish, and farm animals to investigate interspecies differences in probiotics on the species level.

Materials and Methods: A total of 44 fecal and milk samples were collected under aseptic conditions from cattle, buffalo, camel, sheep, goats, and fish. The samples were cultured, and the isolated strains were confirmed biochemically and molecularly using 16S rRNA multiplex polymerase chain reaction (PCR) analysis following DNA extraction from the bacterial isolates.

Results: A total of 31 isolates identified as lactobacilli were isolated from cattle milk, goat feces, sheep feces, fish feces, buffalo milk, camel milk, and goats' milk. Lactobacillus species were identified based on the size of the PCR product. The results showed that different species were different in their lactobacilli content. At the same time, there were some differences between individuals of the same species.

Conclusion: The diversity of probiotic strains isolated from different animal species implies different types of benefits to the host. Although it would be both money - and time-consuming research, discovering the benefit of each of these strains may provide very important information for the health of both human and animal. Furthermore, transferring these beneficial effects either to individuals within the same species or between different species would be of great importance.

Keywords: Lactobacillus, multiplex polymerase chain reaction, probiotics.

1. Brown, A.C., and Valiere, A. (2004) Probiotics and medical nutrition therapy. Nutr. Clin. Care, 7: 56-68. [PubMed] [PMC]

2. Metchnikoff, E., and Metchnikoff, I.I. (1908) The Prolongation of Life: Optimistic Studies. Our post human future. In: Chalmers, M.P., editor. Consequences of the Biotechnology Revolution. New York, London: GP Putnam's Sons. Available from: http://www.books.google.com/books?hl=en&lr=&id=U8bgKGvZJV0C&pgis=1.

3. FAO/WHO. (2011) ICMR-DBT guidelines for evaluation of probiotics in food. Indian J. Med. Res., 134: 22-5. [PubMed] [PMC]

4. Williams, M.D., Ha, C.Y., and Ciorba, M.A. (2010) Probiotics as therapy in gastroenterology. J. Clin. Gastroenterol., 44: 1. [Crossref] [PubMed] [PMC]

5. Hao, Q. and Dong, B.W.T. (2015) Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst. Rev., 3: 2. [Crossref]

6. Ozen, M. and Kocabas, S.D.E. (2015) Probiotics for the prevention of pediatric upper respiratory tract infections: A systematic review. Expert Opin. Biol. Ther., 15: 9-20. [Crossref] [PubMed]

7. Shokryazdan, P., Sieo, C.C., Kalavathy, R., Liang, J.B., Alitheen, N.B., Faseleh, J.M. and Ho, Y.W. (2014) Probiotic potential of Lactobacillus strains with antimicrobial activity against some human pathogenic strains. BioMed. Res. Int., 2014: 927268. [Crossref] [PubMed] [PMC]

8. Bergey, D.H., John, G.H., Noel, R.K., Peter H.A.S. (1994) Bergey's Manual of Determinative Bacteriology. 9th ed. Lippincott Williams & Wilkins, Baltimore.

9. Kwon, H.S., Yang, E.H., Yeon, S.W., Kang, B.H. and Kim, T.Y. (2004) Rapid identification of probiotic Lactobacillus species by multiplex PCR using species-specific primers based on the region extending from 16S rRNA through 23S rRNA. FEMS Microbiol. Lett., 239: 267-275. [Crossref] [PubMed]

10. Lavasanti, S., Dzhambazov, B., Noury, M., Fak, F., Buske, S. and Molin, G. (2010) A novel probiotics mixture exert a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T-cell. PLoS One, 5(2/e9009): 9009.

11. Choi, H.H. and Cho, Y.S. (2016) Fecal microbiota transplantation: Current applications, effectiveness, and future perspectives. Clin. Endosc., 49: 257-265. [Crossref]

12. O'Toole, P.W. and Cooney, J.C. (2008) Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdiscip. Perspect. Infect. Dis., 2008: 1-9. [Crossref] [PubMed] [PMC]

13. Sanders, M.E. (2011) Impact of probiotics on colonizing microbiota of the gut. J. Clin. Gastroenterol., 45: 115-119. [Crossref] [PubMed]

14. Olaya, G.N.N., Ulloa, R.J.C., Velez, R.F.A., Fernandez, D.K.P., Salas, C.S.P. and Gutierrez, F.M.F. (2016) In vitro antiviral activity of Lactobacillus casei and Bifidobacterium adolescentis against rotavirus infection monitored by NSP4 protein production. J. Appl. Microbiol., 120: 1041-1051. [Crossref] [PubMed]

15. Kang, H.S., Lee, J.Y. and Kim, C.J. (2015) Antiviral effects of Lactobacillus ruminis SPM0211 and Bifidobacterium longum SPM1205 and SPM1206 on rotavirus-infected Caco-2 cells and a neonatal mouse model. J. Microbiol., 53: 796-803. [Crossref]

16. Lenoir-Wijnkoop, I., Gerlier, L. and Roy, D.R.G. (2016) The clinical and economic impact of probiotics consumption on respiratory tract infections: Projections for Canada. 0166232. PLoS One, 10: e0166232. [Crossref]

17. Madden, J.A., Plummer, S.F., Tang, J., Garaiova, I., Plummer, N.T., Herbison, M., Hunter, J.O., Shimada, T., Cheng, L. and Shirakawa, T. (2005) Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: A double-blind, placebo-controlled pilot study. Int. Immunopharmacol., 5: 1091-1097. [Crossref]

18. Servin, A.L. (2004) Antagonistic activities of Lactobacilli and Bifidobacteria against microbial pathogens. FEMS Microbiol. Rev., 28: 405-440. [Crossref] [PubMed]

19. Bodera, P. and Chcialowski, A. (2009) Immunomodulatory effect of probiotic bacteria. Recent Pat. Inflamm. Allergy Drug Discov., 3: 58-64. [Crossref] [PubMed]

---